A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD

NCT01163786 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Study was closed due to low accrual before the accrual goal was reached

Conditions

Bronchiolitis Obliterans

Interventions

DRUG: Bortezomib

Sponsor

Northwestern University

Collaborators

[object Object]